You are here

AusPAR: Pembrolizumab (rch)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

14 May 2020
AusPAR Details
AusPAR
Active Ingredient
Pembrolizumab (rch)
Product Name
Keytruda
Sponsor
Merck Sharp & Dohme (Australia) Pty Limited
Submission Number
PM-2019-02526-1-4
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
5 May 2020
Publication Date

14 May 2020